usd digital currency, Knowledge

European Central Bank President Lagarde: As we gradually approach the neutral interest rate, we will further discuss its related issues. The neutral interest rate may be slightly higher than before. We will discuss the neutral interest rate in due course.The annual PPI of the United States in November was 3%, and it was expected to be 2.6%. The previous value was revised from 2.40% to 2.6%. The monthly PPI rate of the United States in November was 0.4%, and it was expected to be 0.2%. The previous value was revised from 0.20% to 0.3%. The monthly rate of core PPI in the United States in November was 0.2%, which was expected to be 0.2%, and the previous value was revised from 0.00% to 0.30%. The annual core PPI of the United States in November was 3.4%, expected to be 3.2%, and the previous value was 3.10%.Spot gold fell by $5 in the short term and is now reported at $2,704 per ounce.

Spot silver fell more than 2.00% in the day and is now reported at $31.26 per ounce; COMEX silver fell more than 3.00% in a day and is now quoted at $31.98 per ounce.The forecast of the European Central Bank assumes that the oil price will be $81.8 per barrel in 2024, $71.8 per barrel in 2025, $70.1 per barrel in 2026 and $69.2 per barrel in 2027.The number of people applying for unemployment benefits for the first time in the week of December 7 in the United States was 242,000, with an expected number of 220,000 and a previous value of 224,000. In the United States, the number of people applying for unemployment benefits in the week ending November 30 was 1.886 million, with an expected 1.875 million and a previous value of 1.871 million.

The yield of German 2-year government bonds fell by 3 basis points to 1.92%, the lowest since December 3.The yield of Italian 10-year government bonds rose by 9 basis points to 3.28%, the highest level since December 2.Baiyang Pharmaceutical Group signed an agreement with Peking University Hospital. On December 12, Baiyang Pharmaceutical Group signed a cooperation agreement with Peking University No.1 Hospital, and obtained the exclusive right to patent, clinical development and registration, production and marketing of "targeted integrin small molecule inhibitor" in Peking University Hospital.